|
Upcoming Events week of Dec 14 - Dec 21 |
|
|
|
|
WVU Cancer Institute partners with Mon General Hospital on Radiation Therapy Unit

Cancer patients from the region will soon be able to have better access to care in Morgantown now that construction is underway on a new radiation therapy unit at Mon General Hospital's Zelda Stein Weiss Cancer Center.
Mon Health System and WVU Medicine officials gathered Dec. 8 for a groundbreaking ceremony at Mon General Hospital. Radiation therapy at Mon General is a partnership between the two Morgantown-based healthcare institutions. Mon Health System is covering the cost of constructing and equipping the new facility, while radiation oncology staff and medical direction will be supplied by the WVU Cancer Institute in collaboration with Mon General oncologists. Read more
Papa John’s offers online promotions to benefit patient care at WVU Cancer Institute
Every day online purchases from Papa Johns - use code HUGGS11 sends $1 to the Norma Mae Huggins Cancer Research Endowment Fund.
Welcome to Aaron Provenzano, DO
Aaron P. Provenzano, DO, an assistant professor of medicine at WVU, specializes in hematology and medical oncology. Dr. Provenzano sees patients with benign hematological disorders as well as malignancies of the head and neck, brain, and lung. He is a 2008 graduate of Ohio University Heritage College of Osteopathic Medicine. He completed an internal medicine residency at WVU in 2011, and a fellowship in hematology/oncology at WVU in 2014. He is board certified in internal medicine by the American Osteopathic Board of Internal Medicine and board eligible in hematology and medical oncology. He previously worked at Wheeling Hospital.
|
|
 |
Cancer clinic staff spread holiday cheer through food drive
The MBRCC clinic is hoping to brighten the holidays for families in Monongalia County. Clinic staff collected 2 large boxes of non-perishable food items for the 34th Annual Toy and Food Drive of Mon County, as part of the United Way Campaign. Dave Staten and Patricia Policicchio were co-coordinators of the drive.
Recognition Awards Nomination deadline approaching
You can now submit nominations for MBRCC Employee Recognition Awards until January 30.
The MBRCC Employee Recognition Awards Committee is now accepting nominations for its annual MBRCC Employee Recognition Awards Program. If you would like to nominate and recognize excellence amongst our faculty, members, staff, employees and Cancer Service Line staff members who devote their professional lives to cancer prevention, care or research in any and all capacities, please download the nomination form on our MBRCC website or complete the hard copy form and send to Donna Tamasco, Room 1805, P.O. Box 9300, or by email to dtamasco@hsc.wvu.edu. Each section of the nomination form must be completed, including an explanation of how the nominee demonstrates "excellence" in the particular guiding principle.
Guidelines and application
Discounted men's basketball tickets available for WVU Medicine employees
The WVU Department of Intercollegiate Athletics is offering $20 tickets for all home Big 12 men’s basketball games to WVU Medicine employees. WVU Men’s Basketball Coach Bob Huggins is a major supporter of basic and clinical research at the WVU Cancer Institute.
Read more
With EBS retiring, OSP will offer more training on WVU+kc
After months of successful use, Information Technology Services and the Office of Sponsored Programs (OSP) are ready for a wider rollout of KC Blue Sheet to the WVU research community. Online and in-person training with this new module of WVU+kc will be offered before the eventual retirement of the Electronic Blue Sheet (EBS) on Jan. 15, 2016. Research community members are encouraged to sign up for an in-person training session before Jan. 15.
To register
For additional information, contact Janet Boyles
|
|
|
|
|
|
|
|
|
Simpson's paradox - aggregating and partitioning populations in health disparities of lung cancer patients.
Fu, P., Panneerselvam, A., Clifford, B., Dowlati, A., Ma, P. C., Zeng, G., Halmos, B., and Leidner, R. Stat Methods Med Res. 2015;24(6):937-948.
Read More
CD44S-hyaluronan interactions protect cells resulting from EMT against anoikis.
Cieply, B., Koontz, C., and Frisch, S. M. Matrix Biol. 2015;48(55):65.
Read More
mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in mice.
Snyder-Talkington, B. N., Dong, C., Sargent, L. M., Porter, D. W., Staska, L. M., Hubbs, A. F., Raese, R., McKinney, W., Chen, B. T., Battelli, L., Lowry, D. T., Reynolds, S. H., Castranova, V., Qian, Y., and Guo, N. L. J Appl Toxicol. 2016;36(1):161-174.
Read More
|
|
|
|
NIH Notices
NIH Requests for Applications
- Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)
(RFA-CA-16-001)
National Cancer Institute
Application Receipt Date(s): February 26, 2016; May 26, 2016; September 26, 2016, by 5:00 PM local time of applicant organization.
- Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
(RFA-CA-16-002)
National Cancer Institute
Application Receipt Date(s): February 26, 2016; May 26, 2016; September 26, 2016, by 5:00 PM local time of applicant organization.
- Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)
(RFA-CA-16-003)
National Cancer Institute
Application Receipt Date(s): February 26, 2016; May 26, 2016; September 26, 2016, by 5:00 PM local time of applicant organization.
- Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33)
(RFA-CA-16-004)
National Cancer Institute
Application Receipt Date(s): February 26, 2016; May 26, 2016; September 26, 2016, by 5:00 PM local time of applicant organization.
- NHLBI Outstanding Investigator Award (OIA) (R35)
(RFA-HL-16-024)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): March 15, 2016; February 15, 2017; February 15, 2018, by 5:00 PM local time of applicant organization.
- NHLBI Early Investigator Award (EIA) (R35)
(RFA-HL-16-025)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): March 15, 2016; February 15, 2017; February 15, 2018, by 5:00 PM local time of applicant organization.
- Clinical Sites for the IDeA States Pediatric Clinical Trials Network (UG1)
(RFA-OD-16-001)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
et al.
Application Receipt Date(s): Not Applicable
- Data Coordinating and Operations Center for the IDeA States Pediatric Clinical Trials Network (U24)
(RFA-OD-16-002)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
et al.
Application Receipt Date(s): Not Applicable
- Environmental Influences on Child Health Outcomes: Patient Reported Outcomes Research Resource Center Core (ECHO PRO Core) (U24)
(RFA-OD-16-003)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
et al.
Application Receipt Date(s): Not applicable
- Environmental Influences on Child Health Outcomes (ECHO) Pediatric Cohorts (UG3/UH3)
(RFA-OD-16-004)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
et al.
Application Receipt Date(s): Not Applicable
- Environmental Influences on Child Health Outcomes (ECHO) Data Analysis Center (U24)
(RFA-OD-16-005)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
et al.
Application Receipt Date(s): April 15, 2016
- Environmental Influences on Child Health Outcomes (ECHO) Coordinating Center (U2C)
(RFA-OD-16-006)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
et al.
Application Receipt Date(s): April 15, 2016
NIH Program Announcements
- Availability of Administrative Supplements to NIGMS Predoctoral Training Grants (Admin Supp)
(PA-16-060)
National Institute of General Medical Sciences
Application Receipt Date(s): March 31, 2016
- Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01)
(PAR-16-049)
National Cancer Institute
Application Receipt Date(s): March 17, 2016; November 17, 2016; March 17, 2017; November 17, 2017, March 17, 2018; November 17, 2018, by 5:00 PM local time of applicant organization.,Not Applicable
- Small Cell Lung Cancer (SCLC) Consortium: Coordinating Center (U24 )
(PAR-16-050)
National Cancer Institute
Application Receipt Date(s): March 17, 2016; November 17, 2016, by 5:00 PM local time of applicant organization.
- Small-Cell Lung Cancer (SCLC) Consortium: Innovative Approaches to the Prevention and Early Detection of Small Cell Lung Cancer (U01)
(PAR-16-051)
National Cancer Institute
Application Receipt Date(s): March 17, 2016; November 17, 2016; March 17, 2017; November 17, 2017, by 5:00 PM local time of applicant organization.
- Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21)
(PAR-16-052)
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Cancer Institute
et al.
Application Receipt Date(s): February 24, 2016, February 22, 2017
- High-End Instrumentation (HEI) Grant Program (S10)
(PAR-16-053)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): May 16, 2016
- Shared Instrumentation Grant (SIG) Program (S10)
(PAR-16-054)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Not Applicable
- Mechanism for Time-Sensitive Drug Abuse Research (R21)
(PAR-16-055)
National Institute on Drug Abuse
Application Receipt Date(s): February 8, 2016; June 8, 2016; November 8, 2016; February 8, 2017; June 8, 2017; November 8, 2017; February 8, 2018; June 8, 2018; November 8, 2018, by 5:00 PM local time of applicant organization.
- Revision Applications for Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (U10)
(PAR-16-056)
National Cancer Institute
Application Receipt Date(s): February 29, 2016; July 8, 2016; October 7, 2016; February 9, 2017; July 7, 2017; October 6, 2017, by 5:00 PM local time of applicant organization.
- Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)
(PAR-16-058)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
- Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)
(PAR-16-059)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Other Funding or Opportunities
Breast Cancer Grants: Breast Cancer Research (Avon Breast Cancer Crusade) Avon Foundation for Women
The Foundation continues its search for new preventive strategies to address the growing number of breast cancer cases around the globe and develop new treatments for those living with metastatic breast cancer today. The 2016 program seeks proposals in these areas to advance understanding of causes of breast cancer, prevention and developing treatments for metastatic breast cancer. Research questions the Foundation hopes to answer to further the development of breast cancer prevention strategies include, but are not limited to, the following:
- Understanding the potential causes of breast cancer and research to develop new preventative strategies
- Understanding metastases and developing new treatments for metastatic breast cancer
Upcoming deadlines: LOI: January 7, 2016. Application (if invited): June 13, 2016
Read More
The RTFCCR/LLS Patient-Focused ImmunotherapyResearch Grant for Blood Cancer(Leukemia & Lymphoma Society)
In a joint collaboration, the RTFCCR and LLS aim to stimulate innovative and clinically relevant cancer research that has the highest potential for near-term patient impact in terms of clinical application, therapeutic outcomes and quality of life. With this competitive grant, the RTFCCR and LLS aspire to advance clinical cancer research worldwide that aims to “educate” a person’s immune system to fight blood cancers.
Upcoming deadlines: LOI: January 25, 2016. Application (if invited): March 15, 2016
Read More
2016 L’Oréal USA For Women in Science fellowship program: Now accepting applications
In the US, this program awards five post‐doctoral women scientists annually with grants of $60,000 each. Applicants are selected from a variety of fields, including the life and physical/material sciences, technology (including computer science), engineering, and mathematics.
To view the application and obtain more information about the L’Oréal USA For Women in Science program.
Applications are due on Friday, February 5, 2016. |
|
|
Dec 24 |
MBRCC clinic will close at 2P for the Winter Holiday |
Dec 25 |
MBRCC clinic is closed for the Winter Holiday |
Dec 31 |
MBRCC clinic will close at 2P |
Jan 1, 2016 |
MBRCC clinic will be closed. |
Jan 8 |
Osborn Program meeting – 12P – 1P, Room 2801
CCB faculty meeting – 1P – 2P, Room 2801 |
Feb 10 |
2016 Spring CCB Seminar Series – 12P – 1P, Room # 2116
Mark W. Jackson, PhD
Case Western Reserve University
Constructing cancer: Identifying novel proteins involved in breast cell transformation and metastasis
|
Feb 17-19 |
19th Annual Meeting of the Translational Research Cancer Centers Consortium (TRCCC) – Seven Springs Mountain Resort, Seven Springs, PA
For registration details and updates |
Feb 18
|
Statler Research Office Seminar Series – 12 – 1 p.m., G112 ESB
Responsible Conduct of Research & Managing Conflict of Interest
Dr. Dan Vasgird, Director
Ms. Joy Edwards, Program Coordinator
Off of Research Integrity and Compliance
Refreshments will be served. Please RSVP at Nancie.Yost@mail.wvu.edu or
(304) 293-3178. |
Mar 3 & 4
|
2016 E.J. Van Liere Convocation and Health Sciences Center Research Day
All faculty, student and staff are encouraged to participate from the Schools of Medicine, Nursing, Dentistry, Pharmacy and Public Health.
Read more |
April 21
|
Statler Research Office Seminar Series – 12 – 1 p.m., G112 ESB
Protecting Intellectual Property (IP) and Export Control Compliance
Mr. Bruce Sparks, Director
Dr. Gary Morris, Associate Director
Technology Transfer Office
Refreshments will be served. Please RSVP at Nancie.Yost@mail.wvu.edu or
(304) 293-3178. |
April 22-24 |
Save the Date for the WVU Cancer Institute’s Annual Spring Gala to be held at
The Greenbrier Resort in
White Sulphur Springs |
|
|
|
|
|
|